What is miraDry?
miraDry, Inc. operates as a specialized medical device manufacturer dedicated to providing permanent, non-invasive solutions for hyperhidrosis. As the developer of the first and only FDA-cleared treatment for this condition, the company occupies a unique niche in the aesthetic and dermatological medical market. Their technology leverages electromagnetic energy to target and eliminate sweat glands, offering a transformative alternative to traditional, temporary treatments. By prioritizing clinical efficacy and supporting healthcare providers with comprehensive training and support, miraDry has established itself as a leader in patient-centric medical innovation.
How much funding has miraDry raised?
miraDry has raised a total of $118.4M across 11 funding rounds:
Debt
$1M
Series C
$35.8M
Debt
$5M
Private Equity
$26M
Series D
$10M
Debt
$1.3M
Debt
$2M
Private Equity
$9.6M
Debt
$2.5M
Debt (2010): $1M, investors not publicly disclosed
Series C (2011): $35.8M featuring Domain Associates, Cross Creek Capital, Morgenthaler Partners, Split Rock Partners, and Aisling Capital
Debt (2013): $5M backed by Domain Associates, The Foundry, LLC, and Morgenthaler Private Equity
Private Equity (2013): $26M with participation from The Foundry, LLC, Morgenthaler Private Equity, and Domain Associates
Series D (2014): $10M led by Domain Associates
Debt (2015): $1.3M, investors not publicly disclosed
Debt (2016): $2M, investors not publicly disclosed
Private Equity (2016): $9.6M, investors not publicly disclosed
Debt (2017): $2.5M, investors not publicly disclosed
Key Investors in miraDry
Domain Associates
A seasoned investment advisory firm established in 1985, specializing in biotech and medical device ventures with a track record of over 190 successful company investments.
Morgenthaler Partners
A premier venture capital and private equity firm with over four decades of experience, focusing on high-growth opportunities within the Life Sciences and Information Technology sectors.
Split Rock Partners
A venture capital firm that provides flexible, patient capital to healthcare and software companies, assisting management teams in navigating complex scaling challenges.
What's next for miraDry?
Looking ahead, the recent strategic investment positions miraDry to further penetrate global markets and expand its clinical applications. The company is expected to leverage this capital to enhance its distribution networks and continue its research and development efforts, ensuring that its flagship technology remains the gold standard for sweat management. As the firm continues to scale, the focus will likely shift toward optimizing operational efficiencies and deepening its footprint in the international medical device sector, supported by a stable foundation of long-term institutional partners.
See full miraDry company page
